Fluvastatin inhibits the expression of tumor necrosis factor-+A7E and activation of nuclear factor-+A7o-B in human endothelial cells stimulated by C-reactive protein-Reference-Cited by-同舟云学术

Fluvastatin inhibits the expression of tumor necrosis factor-+A7E and activation of nuclear factor-+A7o-B in human endothelial cells stimulated by C-reactive protein

Published:2005-03 Issue:1-2 Volume:353 Page:53-60
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Wang Hai-Rong,Li Jian-Jun,Huang Cong-Xin,Jiang Hong

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference39 articles.

1. Inflammation and atherosclerosis;Libby;Circulation,2002

2. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men;Ridker;N. Engl. J. Med.,1997

3. Direct proinflammatory effect of C-reactive protein on human endothelial cells;Pasceri;Circulation,2000

4. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs;Pasceri;Circulation,2001

5. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease;Li;Med. Hypotheses,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered lipid metabolism and serum lipids in chronic kidney disease;Nutritional Management of Renal Disease;2022

2. Mastoparan, a Peptide Toxin from Wasp Venom Conjugated Fluvastatin Nanocomplex for Suppression of Lung Cancer Cell Growth;Polymers;2021-12-02

3. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice;Antimicrobial Agents and Chemotherapy;2018-05

4. Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A;Mediators of Inflammation;2018

5. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial;British Journal of Haematology;2017-03-28